Stocks and Investing Stocks and Investing
Tue, August 23, 2022
Mon, August 22, 2022

Eun Yang Maintained (BPMC) at Strong Buy with Increased Target to $84 on, Aug 22nd, 2022


Published on 2024-10-27 22:47:03 - WOPRAI, Eun Yang
  Print publication without navigation


Eun Yang of Jefferies, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $78 to $84 on, Aug 22nd, 2022.

Eun has made no other calls on BPMC in the last 4 months.



There are 10 other peers that have a rating on BPMC. Out of the 10 peers that are also analyzing BPMC, 3 agree with Eun's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $57 on, Thursday, August 18th, 2022
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $65 on, Tuesday, June 14th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $65 on, Thursday, May 19th, 2022


These are the ratings of the 7 analyists that currently disagree with Eun


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $100 on, Thursday, August 18th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $80 on, Wednesday, August 17th, 2022
  • Derek Archila of "Wells Fargo" Maintained at Sell with Increased Target to $41 on, Wednesday, August 17th, 2022
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Decreased Target to $115 on, Wednesday, August 3rd, 2022
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, August 3rd, 2022
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $80 on, Friday, July 8th, 2022
  • David Lebowitz of "Citigroup" Downgraded from Hold to Strong Sell and Decreased Target to $41 on, Friday, June 10th, 2022
Contributing Sources